Ronald B. Natale

18.9k total citations · 4 hit papers
170 papers, 13.8k citations indexed

About

Ronald B. Natale is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Ronald B. Natale has authored 170 papers receiving a total of 13.8k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Oncology, 90 papers in Pulmonary and Respiratory Medicine and 62 papers in Molecular Biology. Recurrent topics in Ronald B. Natale's work include Lung Cancer Treatments and Mutations (78 papers), Lung Cancer Research Studies (42 papers) and Cancer therapeutics and mechanisms (29 papers). Ronald B. Natale is often cited by papers focused on Lung Cancer Treatments and Mutations (78 papers), Lung Cancer Research Studies (42 papers) and Cancer therapeutics and mechanisms (29 papers). Ronald B. Natale collaborates with scholars based in United States, United Kingdom and Germany. Ronald B. Natale's co-authors include Joan H. Schiller, Roy S. Herbst, Michael Wolf, Steven D. Averbuch, E. David Crawford, Michael F. Sarosdy, V. O. Speights, David P. Wood, Donald L. Trump and Nicholas J. Vogelzang and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Ronald B. Natale

164 papers receiving 13.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer

2003 2.1k citations Ronald B. Natale, Roy S. Herbst et al. profile →
Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer

2003 1.8k citations H. Barton Grossman, Ronald B. Natale et al. New England Journal of Medicine profile →
Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1

2004 1.4k citations Roy S. Herbst, Ronald B. Natale et al. Journal of Clinical Oncology profile →
Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 2

2004 1.4k citations Roy S. Herbst, Ronald B. Natale et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Ronald B. Natale

Since Specialization

Citations

This map shows the geographic impact of Ronald B. Natale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald B. Natale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald B. Natale more than expected).

Fields of papers citing papers by Ronald B. Natale

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald B. Natale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald B. Natale. The network helps show where Ronald B. Natale may publish in the future.

Co-authorship network of co-authors of Ronald B. Natale

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald B. Natale. A scholar is included among the top collaborators of Ronald B. Natale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald B. Natale. Ronald B. Natale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Three Primary Tumors Including EGFR-mutated Non–Small Cell Lung Cancer as First Presentation in Patient With Li-Fraumeni Syndrome 2020 ·Clinical Lung Cancer ·(unknown), Jong Kim, (unknown), (unknown), Eric Vail, Ronald B. Natale	1
2	Phase I Study of MEDI3617, a Selective Angiopoietin-2 Inhibitor Alone and Combined with Carboplatin/Paclitaxel, Paclitaxel, or Bevacizumab for Advanced Solid Tumors 2018 ·Clinical Cancer Research ·David M. Hyman, Naiyer A. Rizvi, Ronald B. Natale, Deborah K. Armstrong, Michael J. Birrer, Lawrence D. Recht, Efrat Dotan, Vicky Makker, Thomas Kaley, (unknown), Matthew Gribbin, Jennifer McDevitt, Dominic W. Lai, Mohammed M. Dar	38
3	P1.01-83 IMpower150: Impact of Chemotherapy Cycles in 1L Metastatic NSCLC in Patients Treated With Atezolizumab + Bevacizumab 2018 ·Journal of Thoracic Oncology ·J. Rothenstein, Alexander I. Spira, Vamsidhar Velcheti, Ronald B. Natale, Mark Kozloff, Michael P. Kosty, Jerome H. Goldschmidt, Julien Mazières, Santiago Ponce Aix, Wenjing Yu, (unknown), (unknown), G. Shankar, Wei‐Hsin Lin, (unknown)	3
4	A Phase I, First-in-Human Study of AMG 780, an Angiopoietin-1 and -2 Inhibitor, in Patients with Advanced Solid Tumors 2016 ·Clinical Cancer Research ·Afshin Dowlati, Gordana Vlahovic, Ronald B. Natale, Erik Rasmussen, Indrajeet Singh, Yuying C. Hwang, John M. Rossi, Michael Bass, Gregory Friberg, Cheryl A. Pickett	16
5	Evaluation of Antitumor Activity Using Change in Tumor Size of the Survivin Antisense Oligonucleotide LY2181308 in Combination with Docetaxel for Second-Line Treatment of Patients with Non–Small-Cell Lung Cancer: A Randomized Open-Label Phase II Study 2014 ·Journal of Thoracic Oncology ·Ronald B. Natale, Fiona Blackhall, Dariusz M. Kowalski, Rodryg Ramlau, Gerold Bepler, Francesco Grossi, Christian Lerchenmüller, Mary Pinder-Schenck, J. Mezger, Sarah Danson, Shirish M. Gadgeel, Yvonne Summers, Sophie Callies, Valérie André, Mayukh Das, Michael Lahn, Denis Talbot	30
6	A phase II study of enzastaurin in combination with erlotinib in patients with previously treated advanced non-small cell lung cancer 2012 ·Lung Cancer ·Christelle Clément-Duchêne, Ronald B. Natale, Thierry Jahan, (unknown), Raymond U. Osarogiagbon, Rachel E. Sanborn, Eric Bernstein, Arkadiusz Z. Dudek, Jane E. Latz, Peipei Shi, Heather A. Wakelee	11
7	Baseline Vascular Endothelial Growth Factor Concentration as a Potential Predictive Marker of Benefit from Vandetanib in Non–Small Cell Lung Cancer 2009 ·Clinical Cancer Research ·Emer O. Hanrahan, Anderson J. Ryan, Helen Mann, S. Kennedy, Peter Langmuir, Ronald B. Natale, Roy S. Herbst, Bruce E. Johnson, John V. Heymach	69
8	Vandetanib Versus Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer: Results From a Two-Part, Double-Blind, Randomized Phase II Study 2009 ·Journal of Clinical Oncology ·Ronald B. Natale, David Bodkin, Ramaswamy Govindan, Bethany Sleckman, Naiyer A. Rizvi, (unknown), Paul Germonpré, Wilfried Eberhardt, Paul K. Stockman, Sarah J. Kennedy, Malcolm Ranson	194
9	PD3-1-8: Motexafin Gadolinium (MGd) is active as a single agent in advanced non-small-cell lung cancer (NSCLC) patients who failed platinum-based chemotherapy: preliminary results of a phase II trial 2007 ·Journal of Thoracic Oncology ·Ronald B. Natale, Garth Nicholas, Frank A. Greco, Ramaswamy Govindan, Pierre Chabot, Kishan J. Pandya, (unknown), Markus F. Renschler	1
10	PD3-3-4: Vandetanib in advanced NSCLC: an ongoing clinical evaluation program 2007 ·Journal of Thoracic Oncology ·Wilfried Eberhardt, S. Korfee, Bruce E. Johnson, Roy S. Herbst, Ronald B. Natale, S. Kennedy, Peter Langmuir	2
11	Raloxifene, an oestrogen‐receptor‐β‐targeted therapy, inhibits androgen‐independent prostate cancer growth: results from preclinical studies and a pilot phase II clinical trial 2005 ·British Journal of Urology ·Ronald Shazer, Anjali Jain, Anna Galkin, Nadya M. Cinman, (unknown), Ronald B. Natale, Mitchell E. Gross, (unknown), (unknown), Stuart Holden, (unknown), David B. Agus	37
12	Randomized phase III trial comparing cisplatin–etoposide to carboplatin–paclitaxel in advanced or metastatic non-small cell lung cancer 2005 ·Annals of Oncology ·Chandra P. Belani, J. S. Lee, Mark A. Socinski, Francisco Robert, David Waterhouse, Kendrith M. Rowland, Rafat Ansari, Rogério Lilenbaum, Ronald B. Natale	106
13	Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer breakdown → 2003 ·New England Journal of Medicine ·H. Barton Grossman, Ronald B. Natale, Catherine M. Tangen, V. O. Speights, Nicholas J. Vogelzang, Donald L. Trump, Ralph W. deVere White, Michael F. Sarosdy, David P. Wood, Derek Raghavan, E. David Crawford	1834
14	Intestinal differentiation and p53 gene alterations in barrett's esophagus and esophageal adenocarcinoma 1994 ·International Journal of Cancer ·Jason H. Moore, (unknown), (unknown), Ronald B. Natale, Mark B. Orringer, David G. Beer	51
15	Multicenter phase II study of brequinar sodium in patients with advanced gastrointestinal cancer 1993 ·Investigational New Drugs ·Malcolm J. Moore, Jean A. Maroun, Francisco Robert, Ronald B. Natale, James A. Neidhart, B.K. Dallaire, (unknown), John W. Gyves	38
16	Multicenter phase II study of brequinar sodium in patients with advanced lung cancer 1993 ·Cancer Chemotherapy and Pharmacology ·Jean A. Maroun, John C. Ruckdeschel, Ronald B. Natale, Robert J. Morgan, B.K. Dallaire, (unknown), John W. Gyves	58
17	An in vivo and in vitro trial of aclarubicin in metastatic breast cancer: a novel approach to the study of analogs 1993 ·Cancer Chemotherapy and Pharmacology ·Ronald B. Natale, Robert L. Cody, Michael S. Simon, Richard Wheeler	6
18	Phase II evaluation of piroxantrone in renal cell carcinoma 1992 ·Investigational New Drugs ·Ace Allen, Michael Wolf, E. David Crawford, Mellar P. Davis, Ronald B. Natale, (unknown)	6
19	Short report: Multicenter phase II trial of brequinar sodium in patients with advanced melanoma 1992 ·Annals of Oncology ·Ronald B. Natale, Ralph A. Wheeler, Miranda A. Moore, B.K. Dallaire, William R. Lynch, (unknown), A.J. Grillo-López, John W. Gyves	38
20	Phase II trial of N-methylformamide in advanced head and neck cancer 1987 ·Investigational New Drugs ·(unknown), Arlene A. Forastiere, Ronald B. Natale, Bonnie J. Takasugi, (unknown)	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact